BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38015725)

  • 1. The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome.
    Kim MS; Park DG; Shin IJ; An YS; Yoon JH
    Clin Nucl Med; 2024 Feb; 49(2):124-130. PubMed ID: 38015725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Gland Uptake on
    Kang SY; Yun JY; Kang YK; Moon BS; Yoon HJ; Yoo MY; Kim BS
    Korean J Radiol; 2023 Jul; 24(7):690-697. PubMed ID: 37404111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech.
    Seckin ZI; Whitwell JL; Utianski RL; Botha H; Ali F; Duffy JR; Clark HM; Machulda MM; Jordan LG; Min HK; Lowe VJ; Josephs KA
    J Neurol; 2020 Sep; 267(9):2603-2611. PubMed ID: 32388831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-phase
    Kim MS; Park DG; An YS; Yoon JH
    Eur J Neurol; 2023 Feb; 30(2):344-352. PubMed ID: 36288409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial 18F-FP-CIT and FDG PET in Fulminant Corticobasal Syndrome.
    Park DG; An YS; Yoon JH
    Clin Nucl Med; 2021 Sep; 46(9):754-755. PubMed ID: 34374680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
    Chun K; Kong E; Cho I
    Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of dual-phase
    Oh M; Lee N; Kim C; Son HJ; Sung C; Oh SJ; Lee SJ; Chung SJ; Lee CS; Kim JS
    Sci Rep; 2021 Jul; 11(1):14992. PubMed ID: 34294739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia.
    Song IU; Kim YD; Cho HJ; Chung SW; Chung YA
    Alzheimer Dis Assoc Disord; 2013; 27(1):51-5. PubMed ID: 22354157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter imaging with [
    Jakobson Mo S; Axelsson J; Jonasson L; Larsson A; Ögren MJ; Ögren M; Varrone A; Eriksson L; Bäckström D; Af Bjerkén S; Linder J; Riklund K
    EJNMMI Res; 2018 Nov; 8(1):100. PubMed ID: 30443684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up Study.
    Hammesfahr S; Antke C; Mamlins E; Beu M; Wojtecki L; Ferrea S; Dinkelbach L; Moldovan AS; Schnitzler A; Müller HW; Südmeyer M
    Neurodegener Dis; 2016; 16(5-6):342-7. PubMed ID: 26978429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain volume patterns in corticobasal syndrome versus idiopathic Parkinson's disease.
    Ferrea S; Junker FB; Hartmann CJ; Dinkelbach L; Eickhoff SB; Moldovan AS; Südmeyer M; Schnitzler A; Schmidt-Wilcke T
    J Neuroimaging; 2022 Jul; 32(4):720-727. PubMed ID: 35099094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yang HJ; Park SH; Seo M; Weon YC; Kim Y
    Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson's disease and normal subjects.
    Jeong YJ; Son HJ; Yoon HJ; Kang DY
    Ann Nucl Med; 2016 Oct; 30(8):572-8. PubMed ID: 27283185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of regional cerebral hypoperfusion in early Parkinson's disease: Clinical implications.
    Chung SJ; Kim SH; Park CW; Lee HS; Yun M; Kim YJ; Sohn YH; Jeong Y; Lee PH
    Parkinsonism Relat Disord; 2024 Apr; 121():106024. PubMed ID: 38377658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.